Form 4 Veraxa Biotech AG - Post de-SPAC: Christoph Samuel Ziegler (Director) For: 20 October

This article reports on a Form 4 filing for Veraxa Biotech AG, specifically detailing an insider transaction involving Director Christoph Samuel Ziegler. The filing is related to post de-SPAC activities and covers transactions up to October 20. The stock symbol VRXA is noted with a 4.95% increase.